EDIT logo

EDIT
Editas Medicine Inc

17,010
Mkt Cap
$254.56M
Volume
899,680.00
52W High
$4.54
52W Low
$1.49
PE Ratio
-2.13
EDIT Fundamentals
Price
$2.68
Prev Close
$2.60
Open
$2.55
50D MA
$2.81
Beta
2.04
Avg. Volume
1.55M
EPS (Annual)
-$1.80
P/B
57.73
Rev/Employee
$465,747.13
$111.99
Loading...
Loading...
News
all
press releases
EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus
Editas narrows Q1 loss as costs fall, but revenues drop sharply. Pipeline focus shifts to in vivo gene editing and lead candidate EDIT-401.
Zacks·15d ago
News Placeholder
More News
News Placeholder
Company News for May 6, 2026
Companies in The News Are: MPC,EDIT,BUD,AEP
Zacks·15d ago
News Placeholder
Chardan Capital Boosts Editas Medicine (NASDAQ:EDIT) Price Target to $4.00
Chardan Capital boosted their price objective on Editas Medicine from $3.50 to $4.00 and gave the stock a 'buy' rating in a research report on Tuesday...
MarketBeat·16d ago
News Placeholder
Editas Medicine (NASDAQ:EDIT) Announces Earnings Results
Editas Medicine (NASDAQ:EDIT - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.26) earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat·16d ago
News Placeholder
Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates
Editas (EDIT) delivered earnings and revenue surprises of +11.86% and -67.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·16d ago
News Placeholder
Editas Medicine (EDIT) to Release Quarterly Earnings on Monday
Editas Medicine (NASDAQ:EDIT) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at...
MarketBeat·17d ago
News Placeholder
Editas Medicine (NASDAQ:EDIT) Rating Increased to Hold at Wall Street Zen
Wall Street Zen raised shares of Editas Medicine from a 'sell' rating to a 'hold' rating in a research note on Saturday...
MarketBeat·20d ago
News Placeholder
Editas Medicine (NASDAQ:EDIT) Stock Passes Above Fifty Day Moving Average - Here's Why
Editas Medicine (NASDAQ:EDIT) Shares Pass Above Fifty Day Moving Average - Time to Sell...
MarketBeat·21d ago
News Placeholder
Editas Medicine (NASDAQ:EDIT) Share Price Passes Above 50 Day Moving Average - Here's What Happened
Editas Medicine (NASDAQ:EDIT) Stock Passes Above Fifty Day Moving Average - Should You Sell...
MarketBeat·29d ago
News Placeholder
Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?
Black Diamond (BDTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·1mo ago
<
1
2
...
>

Latest EDIT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.